Treatment Strategies for Infections With Shiga Toxin-Producing Escherichia coli
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment Strategies for Infections With Shiga Toxin-Producing Escherichia coli
Authors
Keywords
-
Journal
Frontiers in Cellular and Infection Microbiology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-05-06
DOI
10.3389/fcimb.2020.00169
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of antibiotics that diminish disease in a murine model of enterohemorrhagic Escherichia coli infection
- (2020) Sabrina Mühlen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Commensal Enterobacteriaceae Protect against Salmonella Colonization through Oxygen Competition
- (2019) Yael Litvak et al. Cell Host & Microbe
- Phage-Derived Antibacterials: Harnessing the Simplicity, Plasticity, and Diversity of Phages
- (2019) Bi-o Kim et al. Viruses-Basel
- Prevention of EHEC infection by chitosan nano-structure coupled with synthetic recombinant antigen
- (2019) Jaleh Khanifar et al. JOURNAL OF MICROBIOLOGICAL METHODS
- Shiga toxin-induced Haemolytic Uraemic Syndrome and the role of antibiotics
- (2019) Loukas Kakoullis et al. JOURNAL OF INFECTION
- Management of STEC Gastroenteritis: Is There a Role for Probiotics?
- (2019) Mario Giordano et al. International Journal of Environmental Research and Public Health
- Oral immunization of mice with Lactococcus lactis expressing Shiga toxin truncate confers enhanced protection against Shiga toxins of Escherichia coli O157:H7 and Shigella dysenteriae
- (2019) Sagi Sreerohini et al. APMIS
- Chitosan nano-structure loaded with recombinant E. coli O157:H7 antigens as a vaccine candidate can effectively increase immunization capacity
- (2019) Jaleh Khanifar et al. Artificial Cells Nanomedicine and Biotechnology
- Shiga toxin 2eB‐transgenic lettuce vaccine is effective in protecting weaned piglets from edema disease caused by Shiga toxin‐producing Escherichia coli infection
- (2019) Takashi Hamabata et al. ANIMAL SCIENCE JOURNAL
- Development of an Arginine Anchored Nanoglobule with Retrograde Trafficking Inhibitor (Retro-2) for the Treatment of an Enterohemorrhagic Escherichia coli Outbreak
- (2019) Tasneem Gandhi et al. MOLECULAR PHARMACEUTICS
- Outcome of children with Shiga toxin–associated haemolytic uraemic syndrome treated with eculizumab: a matched cohort study
- (2019) Catherine Monet-Didailler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- A nanobody targeting the translocated intimin receptor inhibits the attachment of enterohemorrhagic E. coli to human colonic mucosa
- (2019) David Ruano-Gallego et al. PLoS Pathogens
- Transcriptional and Translational Inhibitors Block SOS Response and Shiga Toxin Expression in Enterohemorrhagic Escherichia coli
- (2019) Michael Berger et al. Scientific Reports
- Inactivation of Escherichia coli O157:H7 and Salmonella on Fresh Herbs by Plant Essential Oils
- (2018) Jitendra Patel et al. Foodborne Pathogens and Disease
- Immunization of pregnant cows with Shiga toxin-2 induces high levels of specific colostral antibodies and lactoferrin able to neutralize E. coli O157:H7 pathogenicity
- (2018) Adriana Albanese et al. VACCINE
- OMV-based vaccine formulations against Shiga toxin producing Escherichia coli strains are both protective in mice and immunogenic in calves
- (2018) Matias Fingermann et al. Human Vaccines & Immunotherapeutics
- Shiga toxin-glycosphingolipid interaction: Status quo of research with focus on primary human brain and kidney endothelial cells
- (2018) Nadine Legros et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Human Recombinant Fab Fragment Neutralizes Shiga Toxin Type 2 Cytotoxic Effects in vitro and in vivo
- (2018) Daniela Luz et al. Toxins
- Blood urea nitrogen to serum creatinine ratio is an accurate predictor of outcome in diarrhea-associated hemolytic uremic syndrome, a preliminary study
- (2017) Werner Keenswijk et al. EUROPEAN JOURNAL OF PEDIATRICS
- Use of Bacteriophages to Control Escherichia coli O157:H7 in Domestic Ruminants, Meat Products, and Fruits and Vegetables
- (2017) Lili Wang et al. Foodborne Pathogens and Disease
- A minireview on the in vitro and in vivo experiments with anti- Escherichia coli O157:H7 phages as potential biocontrol and phage therapy agents
- (2017) Salehe Sabouri et al. INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
- Antimicrobial Effects of Quillaja saponaria Extract Against Escherichia coli O157:H7 and the Emerging Non-O157 Shiga Toxin-Producing E. coli
- (2017) Snigdha Sewlikar et al. JOURNAL OF FOOD SCIENCE
- Intranasal immunization with novel EspA-Tir-M fusion protein induces protective immunity against enterohemorrhagic Escherichia coli O157:H7 challenge in mice
- (2017) Ruqin Lin et al. MICROBIAL PATHOGENESIS
- Efficacy of Urtoxazumab (TMA-15 Humanized Monoclonal Antibody Specific for Shiga Toxin 2) Against Post-Diarrheal Neurological Sequelae Caused by Escherichia coli O157:H7 Infection in the Neonatal Gnotobiotic Piglet Model
- (2017) Rodney Moxley et al. Toxins
- Protection against Shiga Toxins
- (2017) Simona Kavaliauskiene et al. Toxins
- Oral Immunization with Recombinant Lactobacillus acidophilus Expressing espA-Tir-M Confers Protection against Enterohemorrhagic Escherichia coli O157:H7 Challenge in Mice
- (2017) Ruqin Lin et al. Frontiers in Microbiology
- Protection of Human Colon Cells from Shiga Toxin by Plant-based Recombinant Secretory IgA
- (2017) Katsuhiro Nakanishi et al. Scientific Reports
- Probiotic and enterohemorrhagic Escherichia coli: An effective strategy against a deadly enemy?
- (2016) Charlotte Cordonnier et al. CRITICAL REVIEWS IN MICROBIOLOGY
- Inhibitory effects of grape seed extract on growth, quorum sensing, and virulence factors of CDC “top-six” non-O157 Shiga toxin producing E. coli
- (2016) L. Sheng et al. INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
- Treatment ofin vitroenterohemorrhagicEscherichia coliinfection using phage and probiotics
- (2016) C. Dini et al. JOURNAL OF APPLIED MICROBIOLOGY
- Complement contributes to the pathogenesis of Shiga toxin–associated hemolytic uremic syndrome
- (2016) Diana Karpman et al. KIDNEY INTERNATIONAL
- Interactions between the microbiota and pathogenic bacteria in the gut
- (2016) Andreas J. Bäumler et al. NATURE
- Cellular effects of fluorodeoxyglucose: Global changes in the lipidome and alteration in intracellular transport
- (2016) Simona Kavaliauskiene et al. Oncotarget
- Vaccination with DNA Encoding Truncated Enterohemorrhagic Escherichia coli (EHEC) Factor for Adherence-1 Gene (efa-1′) Confers Protective Immunity to Mice Infected with E. coli O157:H7
- (2016) Roberto Riquelme-Neira et al. Frontiers in Cellular and Infection Microbiology
- Type Three Secretion System in Attaching and Effacing Pathogens
- (2016) Meztlli O. Gaytán et al. Frontiers in Cellular and Infection Microbiology
- Oral Delivery Systems for Encapsulated Bacteriophages Targeted at Escherichia coli O157:H7 in Feedlot Cattle
- (2016) K. STANFORD et al. JOURNAL OF FOOD PROTECTION
- Development of Recombinant Lactococcus lactis Displaying Albumin-Binding Domain Variants against Shiga Toxin 1 B Subunit
- (2016) Petra Zadravec et al. PLoS One
- Development of camelid single chain antibodies against Shiga toxin type 2 (Stx2) with therapeutic potential against Hemolytic Uremic Syndrome (HUS)
- (2016) Maria P. Mejías et al. Scientific Reports
- Retrograde Trafficking Inhibitor of Shiga Toxins Reduces Morbidity and Mortality of Mice Infected with Enterohemorrhagic Escherichia coli
- (2015) T. Secher et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- AnIn VitroCombined Antibiotic-Antibody Treatment Eliminates Toxicity from Shiga Toxin-Producing Escherichia coli
- (2015) Craig Skinner et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel actions of 2-deoxy-D-glucose: protection against Shiga toxins and changes in cellular lipids
- (2015) Simona Kavaliauskiene et al. BIOCHEMICAL JOURNAL
- Effect of Rifampicin and Gentamicin on Shiga Toxin 2 Expression Level and the SOS Response inEscherichia coliO104:H4
- (2015) Sukayna M. Fadlallah et al. Foodborne Pathogens and Disease
- Eculizumab in Typical Hemolytic Uremic Syndrome (HUS) With Neurological Involvement
- (2015) Lars Pape et al. MEDICINE
- Novel fusion antigen displayed-bacterial ghosts vaccine candidate against infection of Escherichia coli O157:H7
- (2015) Kun Cai et al. Scientific Reports
- Approaches to treatment of emerging Shiga toxin-producing Escherichia coli infections highlighting the O104:H4 serotype
- (2015) Elias A. Rahal et al. Frontiers in Cellular and Infection Microbiology
- Development and Characterization of Recombinant Antibody Fragments That Recognize and Neutralize In Vitro Stx2 Toxin from Shiga Toxin-Producing Escherichia coli
- (2015) Daniela Luz et al. PLoS One
- Enhanced Virulence of the Escherichia coli O157:H7 Spinach-Associated Outbreak Strain in Two Animal Models Is Associated with Higher Levels of Stx2 Production after Induction with Ciprofloxacin
- (2014) T. Zangari et al. INFECTION AND IMMUNITY
- Peptides derived from phage display libraries as potential neutralizers of Shiga toxin-induced cytotoxicityin vitroandin vivo
- (2014) R.A. Bernedo-Navarro et al. JOURNAL OF APPLIED MICROBIOLOGY
- Protection from Hemolytic Uremic Syndrome by Eyedrop Vaccination with Modified Enterohemorrhagic E. coli Outer Membrane Vesicles
- (2014) Kyoung Sub Choi et al. PLoS One
- Oral immunization with Lactococcus lactis-expressing EspB induces protective immune responses against Escherichia coli O157:H7 in a murine model of colonization
- (2014) B. Ahmed et al. VACCINE
- The Use of Direct-Fed Microbials to Reduce Shedding ofEscherichia coliO157 in Beef Cattle: A Systematic Review and Meta-analysis
- (2014) L. V. Wisener et al. Zoonoses and Public Health
- Effects of Subinhibitory Concentrations of Antimicrobial Agents on Escherichia coli O157:H7 Shiga Toxin Release and Role of the SOS Response
- (2013) Farah J. Nassar et al. Foodborne Pathogens and Disease
- A Single VHH-Based Toxin-Neutralizing Agent and an Effector Antibody Protect Mice against Challenge with Shiga Toxins 1 and 2
- (2013) Jacqueline M. Tremblay et al. INFECTION AND IMMUNITY
- Effect of coiled-coil peptides on the function of the type III secretion system-dependent activity of enterohemorragic Escherichia coli O157:H7 and Citrobacter rodentium
- (2013) Mariano Larzábal et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7
- (2013) Stefan A. Rund et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Effects of Lactobacillus kefiranofaciens M1 isolated from kefir grains on enterohemorrhagic Escherichia coli infection using mouse and intestinal cell models
- (2013) Y.P. Chen et al. JOURNAL OF DAIRY SCIENCE
- Inhibition of Cytotoxicity of Shiga Toxin of Escherichia coli O157:H7 on Vero Cells by Prosopis alba Griseb (Fabaceae) and Ziziphus mistol Griseb (Rhamnaceae) Extracts
- (2013) M. G. PELLARÍN et al. JOURNAL OF FOOD PROTECTION
- Immunization with a Chimera Consisting of the B Subunit of Shiga Toxin Type 2 and Brucella Lumazine Synthase Confers Total Protection against Shiga Toxins in Mice
- (2013) M. P. Mejias et al. JOURNAL OF IMMUNOLOGY
- N-Methyldihydroquinazolinone Derivatives of Retro-2 with Enhanced Efficacy against Shiga Toxin
- (2013) Romain Noel et al. JOURNAL OF MEDICINAL CHEMISTRY
- Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab
- (2013) Y. Delmas et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Production of Hybrid-IgG/IgA Plantibodies with Neutralizing Activity against Shiga Toxin 1
- (2013) Katsuhiro Nakanishi et al. PLoS One
- Mouse in Vivo Neutralization of Escherichia coli Shiga Toxin 2 with Monoclonal Antibodies
- (2013) Luisa Cheng et al. Toxins
- Effects of Antibiotics on Shiga Toxin 2 Production and Bacteriophage Induction by Epidemic Escherichia coli O104:H4 Strain
- (2012) Martina Bielaszewska et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Therapeutic concentrations of antibiotics inhibit Shiga toxin release from enterohemorrhagic E. coli O104:H4 from the 2011 German outbreak
- (2012) Diana Corogeanu et al. BMC MICROBIOLOGY
- Protection by a Recombinant Mycobacterium bovis Bacillus Calmette-Guérin Vaccine Expressing Shiga Toxin 2 B Subunit against Shiga Toxin-Producing Escherichia coli in Mice
- (2012) Jun Fujii et al. Clinical and Vaccine Immunology
- An Outbreak of Shiga Toxin-Producing Escherichia coli O104:H4 Hemolytic Uremic Syndrome in Germany: Presentation and Short-term Outcome in Children
- (2012) S. Loos et al. CLINICAL INFECTIOUS DISEASES
- Assessment of the In Vitro Inhibitory Activity of Specific Probiotic Bacteria Against Different Escherichia coli Strains
- (2012) Luca Mogna et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Lactobacillus plantarum isolated from kefir protects vero cells from cytotoxicity by type-II shiga toxin from Escherichia coli O157:H7
- (2012) Emiliano Kakisu et al. JOURNAL OF DAIRY RESEARCH
- Evaluation of Lactic Acid as an Initial and Secondary Subprimal Intervention for Escherichia coli O157:H7, Non-O157 Shiga Toxin–Producing E. coli, and a Nonpathogenic E. coli Surrogate for E. coli O157:H7
- (2012) C. I. PITTMAN et al. JOURNAL OF FOOD PROTECTION
- Ellagitannin from Quercus infectoria eradicates intestinal colonization and prevents renal injuries in mice infected with Escherichia coli O157 : H7
- (2012) S. P. Voravuthikunchai et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Comparison of efficacies of bovine immune colostral antibody and each immunoglobulin class against verotoxin 2, flagellum and somatic cells of Escherichia coli O157:H7 in mice
- (2012) Tetsurou Seita et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Oral immunization with attenuated Salmonella vaccine expressing Escherichia coli O157:H7 intimin gamma triggers both systemic and mucosal humoral immunity in mice
- (2012) Aline Ferreira Oliveira et al. MICROBIOLOGY AND IMMUNOLOGY
- STEC-HUS, atypical HUS and TTP are all diseases of complement activation
- (2012) Marina Noris et al. Nature Reviews Nephrology
- Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic–uraemic syndrome: an analysis of the German STEC-HUS registry
- (2012) Jan T. Kielstein et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Genome Sequence of E. coli O104:H4 Leads to Rapid Development of a Targeted Antimicrobial Agent against This Emerging Pathogen
- (2012) Dean Scholl et al. PLoS One
- Antibodies to intimin and Escherichia coli-secreted proteins EspA and EspB in sera of Brazilian children with hemolytic uremic syndrome and healthy controls
- (2012) Mirian Guirro et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
- Mucosal priming of the murine immune system against enterohemorrhagic Escherichia coli O157:H7 using Lactococcus lactis expressing the type III secretion system protein EspB
- (2012) B. Ahmed et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
- Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study
- (2012) J. Menne et al. BMJ-British Medical Journal
- An Escherichia coli O157-Specific Engineered Pyocin Prevents and Ameliorates Infection by E. coli O157:H7 in an Animal Model of Diarrheal Disease
- (2011) Jennifer M. Ritchie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Serological Response of Shiga Toxin-Producing Escherichia coli Type III Secreted Proteins in Sera from Vaccinated Rabbits, Naturally Infected Cattle, and Humans
- (2011) David J. Asper et al. Clinical and Vaccine Immunology
- Antimicrobial Activity of a Combination of Mume Fructus, Schizandrae Fructus, and Coptidis Rhizoma on Enterohemorrhagic Escherichia coli O26, O111, and O157 and Its Effect on Shiga Toxin Releases
- (2011) John Hwa Lee et al. Foodborne Pathogens and Disease
- Cross-Reactive Protection against Enterohemorrhagic Escherichia coli Infection by Enteropathogenic E. coli in a Mouse Model
- (2011) Carla Calderon Toledo et al. INFECTION AND IMMUNITY
- Alternative Pathway Activation of Complement by Shiga Toxin Promotes Exuberant C3a Formation That Triggers Microvascular Thrombosis
- (2011) M. Morigi et al. JOURNAL OF IMMUNOLOGY
- Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study
- (2011) Martina Bielaszewska et al. LANCET INFECTIOUS DISEASES
- B-cell epitope KT-12 of enterohemorrhagic Escherichia coli O157:H7: a novel peptide vaccine candidate
- (2011) Cheng-song Wan et al. MICROBIOLOGY AND IMMUNOLOGY
- Protection against Escherichia coli O157:H7 challenge by immunization of mice with purified Tir proteins
- (2011) Hong-ying Fan et al. MOLECULAR BIOLOGY REPORTS
- Bifidobacteria can protect from enteropathogenic infection through production of acetate
- (2011) Shinji Fukuda et al. NATURE
- Eculizumab in Severe Shiga-Toxin–Associated HUS
- (2011) Anne-Laure Lapeyraque et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rescue from lethal Shiga toxin 2-induced renal failure with a cell-permeable peptide
- (2011) Deborah J. Stearns-Kurosawa et al. PEDIATRIC NEPHROLOGY
- A Glucosylceramide Synthase Inhibitor Protects Rats Against the Cytotoxic Effects of Shiga Toxin 2
- (2011) CLAUDIA SILBERSTEIN et al. PEDIATRIC RESEARCH
- Immunogenicity of a plant-derived edible chimeric EspA, Intimin and Tir of Escherichia coli O157:H7 in mice
- (2011) Jafar Amani et al. PLANT SCIENCE
- Prospective Genomic Characterization of the German Enterohemorrhagic Escherichia coli O104:H4 Outbreak by Rapid Next Generation Sequencing Technology
- (2011) Alexander Mellmann et al. PLoS One
- Inhibitors of Intravesicular Acidification Protect Against Shiga Toxin in a pH-Independent Manner
- (2011) Anne Berit Dyve Lingelem et al. TRAFFIC
- Vaccination of attenuated EIS-producing Salmonella induces protective immunity against enterohemorrhagic Escherichia coli in mice
- (2011) Jiang Gu et al. VACCINE
- Novel fusion protein protects against adherence and toxicity of enterohemorrhagic Escherichia coli O157:H7 in mice
- (2011) Xiang Gao et al. VACCINE
- Decrease in Shiga toxin expression using a minimal inhibitory concentration of rifampicin followed by bactericidal gentamicin treatment enhances survival of Escherichia coli O157:H7-infected BALB/c mice
- (2011) Elias A Rahal et al. Annals of Clinical Microbiology and Antimicrobials
- Rectal single dose immunization of mice with Escherichia coli O157:H7 bacterial ghosts induces efficient humoral and cellular immune responses and protects against the lethal heterologous challenge
- (2011) Ulrike Beate Mayr et al. Microbial Biotechnology
- Different Classes of Antibiotics Differentially Influence Shiga Toxin Production
- (2010) C. M. McGannon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vivo and Ex Vivo Evaluations of Bacteriophages e11/2 and e4/1c for Use in the Control of Escherichia coli O157:H7
- (2010) L. Rivas et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Intragastric immunization of mice with enterohemorrhagic Escherichia coli O157:H7 bacterial ghosts reduces mortality and shedding and induces a Th2-type dominated mixed immune response
- (2010) Kun Cai et al. CANADIAN JOURNAL OF MICROBIOLOGY
- Salmonella enterica Serovar Typhimurium Vaccine Strains Expressing a Nontoxic Shiga-Like Toxin 2 Derivative Induce Partial Protective Immunity to the Toxin Expressed by Enterohemorrhagic Escherichia coli
- (2010) R. L. G. Rojas et al. Clinical and Vaccine Immunology
- Identification of a novel linear epitope on EspA from enterohemorrhagic E. coli using a neutralizing and protective monoclonal antibody
- (2010) Shu Yu et al. CLINICAL IMMUNOLOGY
- ProbioticLactobacillus reuteriAmeliorates Disease Due to EnterohemorrhagicEscherichia coliin Germfree Mice
- (2010) Kathryn A. Eaton et al. INFECTION AND IMMUNITY
- Role of rifampicin in limiting Escherichia coli O157:H7 Shiga-like toxin expression and enhancement of survival of infected BALB/c mice
- (2010) Elias A. Rahal et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antimicrobial action of the American cranberry constituents; phenolics, anthocyanins, and organic acids, against Escherichia coli O157:H7
- (2010) Alison Lacombe et al. INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
- Shiga Toxin 2–Specific but Not Shiga Toxin 1–Specific Human Monoclonal Antibody Protects Piglets Challenged with EnterohemorrhagicEscherichia coliProducing Shiga Toxin 1 and Shiga Toxin 2
- (2010) Kwang‐il Jeong et al. JOURNAL OF INFECTIOUS DISEASES
- Glycan-based high-affinity ligands for toxins and pathogen receptors
- (2010) Ashish A. Kulkarni et al. MEDICINAL RESEARCH REVIEWS
- Immunogenic properties of chimeric protein from espA, eae and tir genes of Escherichia coli O157:H7
- (2010) Jafar Amani et al. VACCINE
- Neutralizing antibodies to Shiga toxin type 2 (Stx2) reduce colonization of mice by Stx2-expressing Escherichia coli O157:H7
- (2010) Krystle L. Mohawk et al. VACCINE
- Enhanced immunogenicity of a novel Stx2Am-Stx1B fusion protein in a mice model of enterohemorrhagic Escherichia coli O157:H7 infection
- (2010) Kun Cai et al. VACCINE
- Safety and Pharmacokinetics of Urtoxazumab, a Humanized Monoclonal Antibody, against Shiga-Like Toxin 2 in Healthy Adults and in Pediatric Patients Infected with Shiga-Like Toxin-Producing Escherichia coli
- (2009) E. L. Lopez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety and Pharmacokinetics of Chimeric Anti-Shiga Toxin 1 and Anti-Shiga Toxin 2 Monoclonal Antibodies in Healthy Volunteers
- (2009) M. Bitzan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- An Engineered R-Type Pyocin Is a Highly Specific and Sensitive Bactericidal Agent for the Food-Borne Pathogen Escherichia coli O157:H7
- (2009) D. Scholl et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A DNA Vaccine Encoding the Enterohemorragic Escherichia coli Shiga-Like Toxin 2 A2 and B Subunits Confers Protective Immunity to Shiga Toxin Challenge in the Murine Model
- (2009) L. V. Bentancor et al. Clinical and Vaccine Immunology
- Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections
- (2009) Antonio Serna et al. CURRENT OPINION IN GASTROENTEROLOGY
- Expression of EspA inLactococcus lactisNZ9000 and the detection of its immune effect in vivo and vitro
- (2009) Jingjing Luan et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- An Orally Applicable Shiga Toxin Neutralizer Functions in the Intestine To Inhibit the Intracellular Transport of the Toxin
- (2009) M. Watanabe-Takahashi et al. INFECTION AND IMMUNITY
- Host range and lytic capability of four bacteriophages against bovine and clinical human isolates of Shiga toxin-producingEscherichia coliO157:H7
- (2009) Y.D. Niu et al. JOURNAL OF APPLIED MICROBIOLOGY
- Screening and Analysis of Spices with Ability to Suppress Verocytotoxin Production by Escherichia coli O157
- (2009) Niro Takemasa et al. JOURNAL OF FOOD SCIENCE
- Shiga Toxin Activates Complement and Binds Factor H: Evidence for an Active Role of Complement in Hemolytic Uremic Syndrome
- (2009) Dorothea Orth et al. JOURNAL OF IMMUNOLOGY
- Gnotobiotic Piglet Infection Model for Evaluating the Safe Use of Antibiotics againstEscherichia coliO157:H7 Infection
- (2009) Quanshun Zhang et al. JOURNAL OF INFECTIOUS DISEASES
- Fusion expression and immunogenicity of EHEC EspA-Stx2Al protein: Implications for the vaccine development
- (2009) Yan Cheng et al. JOURNAL OF MICROBIOLOGY
- Enterohemorrhagic Escherichia coli trivalent recombinant vaccine containing EspA, intimin and Stx2 induces strong humoral immune response and confers protection in mice
- (2009) Jiang Gu et al. MICROBES AND INFECTION
- Glycosphingolipid Requirements for Endosome-to-Golgi Transport of Shiga Toxin
- (2009) Hilde Raa et al. TRAFFIC
- Towards an attenuated enterohemorrhagic Escherichia coli O157:H7 vaccine characterized by a deleted ler gene and containing apathogenic Shiga toxins
- (2009) Jun Liu et al. VACCINE
- Immunogenicity of a novel Stx2B–Stx1B fusion protein in a mice model of Enterohemorrhagic Escherichia coli O157:H7 infection
- (2009) Xiang Gao et al. VACCINE
- Bacteriophages Reduce Experimental Contamination of Hard Surfaces, Tomato, Spinach, Broccoli, and Ground Beef by Escherichia coli O157:H7
- (2008) T. Abuladze et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Prevention and treatment of enterohemorrhagicEscherichia coliinfections in humans
- (2008) Dorothea Orth et al. Expert Review of Anti-Infective Therapy
- Subtype-Specific Suppression of Shiga Toxin 2 Released from Escherichia coli upon Exposure to Protein Synthesis Inhibitors
- (2008) M. G. Pedersen et al. JOURNAL OF CLINICAL MICROBIOLOGY
- The effect of probiotics and organic acids on Shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7
- (2008) Christine M. Carey et al. JOURNAL OF MICROBIOLOGICAL METHODS
- Subcutaneous and intranasal immunization with type III secreted proteins can prevent colonization and shedding of Escherichia coli O157:H7 in mice
- (2008) Shawn Babiuk et al. MICROBIAL PATHOGENESIS
- A nasal vaccine comprising B-subunit derivative of Shiga toxin 2 for cross-protection against Shiga toxin types 1 and 2
- (2008) Takao Tsuji et al. VACCINE
- Efficient immune responses against Intimin and EspB of enterohaemorragic Escherichia coli after intranasal vaccination using the TLR2/6 agonist MALP-2 as adjuvant
- (2008) Angel Cataldi et al. VACCINE
- The immunogenicity of fusion protein linking the carboxyl terminus of the B subunit of Shiga toxin 2 to the B subunit of E. coli heat-labile enterotoxin
- (2007) Xue Qin Ran et al. VETERINARY MICROBIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More